Evidence map›Paper›PMID 36064643›Full record

ArticleTrials2022

OnTrack Chile for people with early psychosis: a study protocol for a Hybrid Type 1 trial.

Franco Mascayano, Iruma Bello, Howard Andrews, Diego Arancibia, Tamara Arratia, María Soledad Burrone, Sarah Conover, Kim Fader, Maria Jose Jorquera, Mauricio Gomez and 18 more

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04247711 (On Track Chile For First Episode Psychosis), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04247711 naunknown statusnot on this map

On Track Chile For First Episode Psychosis

TypeinterventionalSponsorUniversity of ChileRan2021 to 2025Enrolled300ConditionsPsychosisArmsOTCH, Usual FEP Services
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 9 institutions in 3 countries.

Franco Mascayano *Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA.
Iruma Bello *New York State Psychiatric Institute, New York, USA.
Howard AndrewsNew York State Psychiatric Institute, New York, USA.
Diego ArancibiaInstituto de Ciencias de la Salud, Universidad de O'Higgins, Rancagua, Chile.
Tamara ArratiaInstituto de Ciencias de la Salud, Universidad de O'Higgins, Rancagua, Chile.
María Soledad BurroneInstituto de Ciencias de la Salud, Universidad de O'Higgins, Rancagua, Chile.
Sarah ConoverSilberman School of Social Work, Hunter College, New York, USA.
Kim FaderDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA.
Maria Jose JorqueraSchool of Public Health, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
Mauricio GomezSchool of Public Health, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
Sergio MalverdeSchool of Public Health, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
Gonzalo Martínez-AlésDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA.
Jorge RamírezSchool of Public Health, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
Gabriel ReginattoInstituto de Ciencias de la Salud, Universidad de O'Higgins, Rancagua, Chile.
Alexandra Restrepo-HenaoDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA.
Robert A RosencheckResearch, Education and Clinical Center, VA New England Mental Illness, West Haven, CT, USA.
Sara SchillingSchool of Public Health, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
Thomas E SmithNew York State Psychiatric Institute, New York, USA.
Gonzalo Soto-BrandtSchool of Public Health, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
Eric TapiaSchool of Public Health, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
Tamara TapiaSchool of Public Health, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
Paola VelascoInstituto de Ciencias de la Salud, Universidad de O'Higgins, Rancagua, Chile.
Melanie M WallNew York State Psychiatric Institute, New York, USA.
Lawrence H YangDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA.
Leopoldo J CabassaGeorge Warren Brown School of Social Work, Washington University in St. Louis, St. Louis, MO, USA.
Ezra SusserDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA.
Lisa DixonNew York State Psychiatric Institute, New York, USA.
Rubén AlvaradoInstituto de Ciencias de la Salud, Universidad de O'Higgins, Rancagua, Chile. ruben.alvarado@uv.cl.
University of Chile · CLColumbia University · USUniversity of O'Higgins · CLNew York State Psychiatric InstituteHunter College · USNew York University · USUniversidad de Antioquia · COWashington University in St. Louis · USYale University · US

Funding

OnTrackChile for First Episode PsychosisR01MH115502 · NIMH · UNIVERSIDAD DE O'HIGGINS · PI ALVARADO, RUBEN VLADIMIR, CABASSA, LEOPOLDO J · 2018 to 2022
$2.9M
NIMH NIH HHS 1U01MH115502-01NIMH NIH HHS R01 MH115502
6 · The paper itself

Abstract

backgroundSubstantial data from high-income countries support early interventions in the form of evidence-based Coordinated Specialty Care (CSC) for people experiencing First Episode Psychosis (FEP) to ameliorate symptoms and minimize disability. Chile is unique among Latin American countries in providing universal access to FEP services through a national FEP policy that mandates the identification of FEP individuals in primary care and guarantees delivery of community-based FEP treatments within a public health care system. Nonetheless, previous research has documented that FEP services currently provided at mental health clinics do not provide evidence-based approaches. This proposal aims to address this shortfall by first adapting OnTrackNY (OTNY), a CSC program currently being implemented across the USA, into OnTrackChile (OTCH), and then examine its effectiveness and implementation in Chile.

methodsThe Dynamic Adaptation Process will be used first to inform the adaptation and implementation of OTCH to the Chilean context. Then, a Hybrid Type 1 trial design will test its effectiveness and cost and evaluate its implementation using a cluster-randomized controlled trial (RCT) (N = 300 from 21 outpatient clinics). The OTCH program will be offered in half of these outpatient clinics to individuals ages 15-35. Usual care services will continue to be offered at the other clinics. Given the current COVID-19 pandemic, most research and intervention procedures will be conducted remotely. The study will engage participants over the course of 2 years, with assessments administered at enrollment, 12 months, and 24 months. Primary outcomes include implementation (fidelity, acceptability, and uptake) and service outcomes (person-centeredness, adherence, and retention). Secondary outcomes comprise participant-level outcomes such as symptoms, functioning, and recovery orientation. Over the course of the study, interviews and focus groups with stakeholders will be conducted to better understand the implementation of OTCH. DISCUSSION: Findings from this study will help determine the feasibility, effectiveness, and cost for delivering CSC services in Chile. Lessons learned about facilitators and barriers related to the implementation of the model could help inform the approach needed for these services to be further expanded throughout Latin America.

trial registrationwww. CLINICALTRIALS: gov NCT04247711 . Registered 30 January 2020. TRIAL STATUS: The OTCH trial is currently recruiting participants. Recruitment started on March 1, 2021, and is expected to be completed by December 1, 2022. This is the first version of this protocol (5/12/2021).

Indexed as

COVID-19Psychotic DisordersAdolescentAdultChileHumansRandomized Controlled Trials as TopicYoung AdultCoordinated specialty careEarly psychosisGlobal mental healthHybrid Type 1 trialSpecialized coordinated services for first episode psychosis

Identifiers

PMID36064643
PMCPMC9444092
OpenAlexW4294647480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.